These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24161478)

  • 21. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Liquid Chromatography-Tandem Mass Spectrometric Method for Quantification of Mycophenolic Acid and Its Glucuronides in Dried Blood Spot Samples.
    Iboshi H; Yamaguchi H; Suzuki H; Kikuchi M; Tanaka M; Takasaki S; Takahashi A; Maekawa M; Shimada M; Matsuda Y; Okada Y; Mano N
    Ther Drug Monit; 2017 Dec; 39(6):648-653. PubMed ID: 29040229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of irinotecan and its metabolite SN-38 in dried blood spots using high-performance liquid-chromatography with fluorescence detection.
    Hahn RZ; Arnhold PC; Andriguetti NB; Schneider A; Klück HM; Dos Reis SL; Bastiani MF; Kael I; da Silva ACC; Schwartsmann G; Antunes MV; Linden R
    J Pharm Biomed Anal; 2018 Feb; 150():51-58. PubMed ID: 29216585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application.
    Kocur A; Rubik J; Czarnowski P; Czajkowska A; Marszałek D; Sierakowski M; Górska M; Pawiński T
    Pharmacol Rep; 2023 Aug; 75(4):1026-1042. PubMed ID: 37452967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination.
    Paniagua-González L; Lendoiro E; Otero-Antón E; López-Rivadulla M; de-Castro-Ríos A; Cruz A
    J Pharm Biomed Anal; 2022 Jan; 208():114443. PubMed ID: 34735994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
    Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP
    Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of non-contact hematocrit prediction technologies to overcome hematocrit effects on immunosuppressant quantification from dried blood spots.
    Deprez S; Heughebaert L; Boffel L; Stove CP
    Talanta; 2023 Mar; 254():124111. PubMed ID: 36462285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement.
    den Burger JC; Wilhelm AJ; Chahbouni AC; Vos RM; Sinjewel A; Swart EL
    Anal Bioanal Chem; 2015 Jan; 407(2):621-7. PubMed ID: 25374126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients.
    Veenhof H; Koster RA; Alffenaar JC; Berger SP; Bakker SJL; Touw DJ
    Transplantation; 2017 Jul; 101(7):1727-1733. PubMed ID: 27906832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
    Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
    Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
    Berm EJ; Brummel-Mulder E; Paardekooper J; Hak E; Wilffert B; Maring JG
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2349-53. PubMed ID: 24493333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry.
    Nguyen Thi MT; Capron A; Mourad M; Wallemacq P
    Clin Biochem; 2013 Dec; 46(18):1909-11. PubMed ID: 24060731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.
    Baraldo M; Isola M; Feruglio MT; Francesconi A; Franceschi L; Tursi V; Livi U; Furlanut M
    Transplant Proc; 2005 Jun; 37(5):2240-3. PubMed ID: 15964387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic drug monitoring by dried blood spot: progress to date and future directions.
    Wilhelm AJ; den Burger JC; Swart EL
    Clin Pharmacokinet; 2014 Nov; 53(11):961-73. PubMed ID: 25204403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring.
    Antunes MV; Charão MF; Linden R
    Clin Biochem; 2016 Sep; 49(13-14):1035-46. PubMed ID: 27179588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients.
    Veenhof H; Koster RA; Alffenaar JC; van den Berg AP; de Groot MR; Verschuuren EAM; Berger SP; Bakker SJL; Touw DJ
    Clin Chem Lab Med; 2019 Nov; 57(12):1854-1862. PubMed ID: 30939110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
    Amara AB; Else LJ; Carey D; Khoo S; Back DJ; Amin J; Emery S; Puls RL
    Ther Drug Monit; 2017 Dec; 39(6):654-658. PubMed ID: 28953037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
    Muller H; Solari S; Zuniga C; Guerra I; Troncoso J; Ovalle R; Morente J; Pedreros C
    Transplant Proc; 2007 Apr; 39(3):596-9. PubMed ID: 17445553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer.
    Capiau S; Stove VV; Lambert WE; Stove CP
    Anal Chem; 2013 Jan; 85(1):404-10. PubMed ID: 23190205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots.
    Klak A; Pauwels S; Vermeersch P
    Diagnosis (Berl); 2019 Mar; 6(1):57-68. PubMed ID: 30808156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.